These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6402314)

  • 1. The mode of action of cytotoxic and antitumor 1-nitroacridines. II. In vivo enzyme-mediated covalent binding of a 1-nitroacridine derivative, Ledakrin or Nitracrine, with dna and other macromolecules of mammalian or bacterial cells.
    Pawlak JW; Pawlak K; Konopa J
    Chem Biol Interact; 1983 Feb; 43(2):151-73. PubMed ID: 6402314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The mode of action of cytotoxic and antitumor 1-nitroacridines. III. In vivo interstrand cross-linking of DNA of mammalian or bacterial cells by 1-nitroacridines.
    Konopa J; Pawlak JW; Pawlak K
    Chem Biol Interact; 1983 Feb; 43(2):175-97. PubMed ID: 6402315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 32P-post-labeling analysis of DNA adduct formation by antitumor drug nitracrine (Ledakrin) and other nitroacridines in different biological systems.
    Bartoszek A; Konopa J
    Biochem Pharmacol; 1989 Apr; 38(8):1301-12. PubMed ID: 2706021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of DNA-protein crosslinks by antitumor 1-nitro-9-aminoacridines in L1210 leukemia cells.
    Woynarowski JM; McNamee H; Szmigiero L; Beerman TA; Konopa J
    Biochem Pharmacol; 1989 Nov; 38(22):4095-101. PubMed ID: 2557039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro binding of metabolically activated [14C]-ledakrin, or 1-nitro-9-14C-(3'-dimethylamino-N-propylamino) acridine, a new antitumor and DNA cross-linking agent, to macromolecules of subcellular fractions isolated from rat liver and HeLa cells.
    Pawlak JW; Konopa J
    Biochem Pharmacol; 1979 Dec; 28(23):3391-402. PubMed ID: 43732
    [No Abstract]   [Full Text] [Related]  

  • 6. DNA damage in HeLa s3 cells by an antitumor drug Ledakrin and other antitumor 1-nitro-9-aminoacridines.
    Woynarowski JM; Bartoszek A; Konopa J
    Chem Biol Interact; 1984 May; 49(3):311-28. PubMed ID: 6722943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The mode of action of cytotoxic and antitumor 1-nitroacridines. I. The 1-nitroacridines do not exert their cytotoxic effects by physicochemical binding with DNA.
    Pawlak K; Matuszkiewicz A; Pawlak JW; Konopa J
    Chem Biol Interact; 1983 Feb; 43(2):131-49. PubMed ID: 6825197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The mechanism of inhibition of DNA replication in HeLa S3 cells by the antitumor drug Ledakrin and other antitumor 1-nitro-9-aminoacridines.
    Woynarowski JM; Bartoszek A
    Biochim Biophys Acta; 1985 Jun; 825(2):244-53. PubMed ID: 4005263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 32P-post-labelling analysis of nucleobases involved in the formation of DNA adducts by antitumor 1-nitroacridines.
    Bartoszek A; Dackiewicz P; Konopa J
    Chem Biol Interact; 1997 Feb; 103(2):131-9. PubMed ID: 9055871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Covalent binding of 1-nitro-9-(3-dimethyl-n-propylamino) acridine, a new antitumor drug, to DNA of Ehrlich ascites tumor cells in vivo.
    Konopa J; Koldej K; Pawlak JW
    Chem Biol Interact; 1976 Apr; 13(1):99-103. PubMed ID: 1260948
    [No Abstract]   [Full Text] [Related]  

  • 11. Intercalation model for DNA-cross linking in a 1-nitro-9-aminoacridine derivative, an analog of the antitumor agent "ledakrin" (nitracrine).
    Stallings WC; Glusker JP; Carrell HL; Bogucka-Ledóchowska M; Ledóchowski A; Stezowski JJ
    J Biomol Struct Dyn; 1984 Dec; 2(3):511-24. PubMed ID: 6400911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Products of metabolic activation of the antitumor drug ledakrin (nitracrine) in vitro.
    Gorlewska K; Mazerska Z; Sowiński P; Konopa J
    Chem Res Toxicol; 2001 Jan; 14(1):1-10. PubMed ID: 11170502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Some properties of the irreversible complexes of nitracrine (ledakrin, C-283) with polynucleotides.
    Gniazdowski M; Ciesielska E; Szmigiero L
    Chem Biol Interact; 1981 Mar; 34(3):355-66. PubMed ID: 6161711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reductive metabolism and hypoxia-selective toxicity of nitracrine.
    Wilson WR; Denny WA; Stewart GM; Fenn A; Probert JC
    Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1235-8. PubMed ID: 3744944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoxia-selective antitumor agents. 2. Electronic effects of 4-substituents on the mechanisms of cytotoxicity and metabolic stability of nitracrine derivatives.
    Wilson WR; Thompson LH; Anderson RF; Denny WA
    J Med Chem; 1989 Jan; 32(1):31-8. PubMed ID: 2909741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro DNA crosslinking by Ledakrin, an antitumor derivative of 1-nitro-9-aminoacridine.
    Bartoszek A; Dackiewicz P; Składanowski A; Konopa J
    Chem Biol Interact; 1997 Feb; 103(2):141-51. PubMed ID: 9055872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of intercalating and groove-binding ligands on formation of covalent complexes between nitracrine (Ledakrin, C-283) or 8-methoxypsoralen and DNA.
    Wilmańska D; Małagocka E; Szmigiero L; Gniazdowski M
    Biochim Biophys Acta; 1984 Jul; 782(3):285-94. PubMed ID: 6733111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of ledakrin on DNA and cell cycle in HeLa S3 cells.
    Woynarowski JM; Konopa J
    Drugs Exp Clin Res; 1986; 12(6-7):517-21. PubMed ID: 3743369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of G(2) arrest enhances cell death induced by the antitumor 1-nitroacridine derivative, Nitracrine.
    Skladanowski A
    Apoptosis; 2002 Aug; 7(4):347-59. PubMed ID: 12101394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crosslinking of cellular DNA by nitracrine and furocoumarin derivatives.
    Studzian K; Tołwińska-Stańczyk Z; Wilmańska D; Palumbo M; Gniazdowski M
    Neoplasma; 1999; 46(1):50-3. PubMed ID: 10355534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.